Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

USA - NASDAQ:BLBD - US0953061068 - Common Stock

56.22 USD
-1.74 (-3%)
Last: 9/15/2025, 4:08:09 PM
56.24 USD
+0.02 (+0.04%)
After Hours: 9/15/2025, 4:08:09 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BLBD. BLBD was compared to 128 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on BLBD. These ratings would make BLBD suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 20.14%, BLBD belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
BLBD has a better Return On Equity (52.24%) than 98.44% of its industry peers.
With an excellent Return On Invested Capital value of 28.56%, BLBD belongs to the best of the industry, outperforming 99.22% of the companies in the same industry.
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROIC 28.56%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLBD has a better Profit Margin (8.16%) than 64.06% of its industry peers.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin (10.02%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BLBD has grown nicely.
BLBD has a worse Gross Margin (19.47%) than 73.44% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BLBD has more shares outstanding
Compared to 5 years ago, BLBD has more shares outstanding
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BLBD has an Altman-Z score of 6.81. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
BLBD has a Altman-Z score of 6.81. This is amongst the best in the industry. BLBD outperforms 87.50% of its industry peers.
BLBD has a debt to FCF ratio of 0.64. This is a very positive value and a sign of high solvency as it would only need 0.64 years to pay back of all of its debts.
The Debt to FCF ratio of BLBD (0.64) is better than 89.06% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that BLBD is not too dependend on debt financing.
BLBD has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: BLBD outperforms 57.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Altman-Z 6.81
ROIC/WACC2.88
WACC9.9%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.58. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a worse Current ratio (1.58) than 71.09% of its industry peers.
BLBD has a Quick Ratio of 1.58. This is a bad value and indicates that BLBD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, BLBD is doing worse than 69.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.92
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.95% over the past year.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
Looking at the last year, BLBD shows a quite strong growth in Revenue. The Revenue has grown by 9.31% in the last year.
BLBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.74% yearly.
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%

3.2 Future

BLBD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.19% yearly.
The Revenue is expected to grow by 4.99% on average over the next years.
EPS Next Y19.15%
EPS Next 2Y11.39%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y6.93%
Revenue Next 3Y8.1%
Revenue Next 5Y4.99%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.64, BLBD is valued correctly.
82.81% of the companies in the same industry are more expensive than BLBD, based on the Price/Earnings ratio.
BLBD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 13.02 indicates a correct valuation of BLBD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 83.59% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. BLBD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.64
Fwd PE 13.02
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLBD is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued cheaply inside the industry as 88.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.46
EV/EBITDA 11.12
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.76
PEG (5Y)0.89
EPS Next 2Y11.39%
EPS Next 3Y11.19%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (9/15/2025, 4:08:09 PM)

After market: 56.24 +0.02 (+0.04%)

56.22

-1.74 (-3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners119.23%
Inst Owner Change-5.43%
Ins Owners0.55%
Ins Owner Change-4.52%
Market Cap1.78B
Analysts83.08
Price Target57.7 (2.63%)
Short Float %16.04%
Short Ratio8.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.14%
Min EPS beat(2)-0.8%
Max EPS beat(2)21.07%
EPS beat(4)3
Avg EPS beat(4)11.51%
Min EPS beat(4)-0.8%
Max EPS beat(4)21.07%
EPS beat(8)7
Avg EPS beat(8)46.57%
EPS beat(12)10
Avg EPS beat(12)-86.96%
EPS beat(16)11
Avg EPS beat(16)-81.93%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)3.33%
Revenue beat(4)2
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.34%
Revenue beat(12)9
Avg Revenue beat(12)6.43%
Revenue beat(16)11
Avg Revenue beat(16)6.25%
PT rev (1m)9.7%
PT rev (3m)9.7%
EPS NQ rev (1m)1.47%
EPS NQ rev (3m)7.57%
EPS NY rev (1m)6.96%
EPS NY rev (3m)6.96%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-4.06%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 14.64
Fwd PE 13.02
P/S 1.25
P/FCF 12.46
P/OCF 10.71
P/B 8.04
P/tB 11.08
EV/EBITDA 11.12
EPS(TTM)3.84
EY6.83%
EPS(NY)4.32
Fwd EY7.68%
FCF(TTM)4.51
FCFY8.03%
OCF(TTM)5.25
OCFY9.34%
SpS44.81
BVpS7
TBVpS5.07
PEG (NY)0.76
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROCE 41.05%
ROIC 28.56%
ROICexc 56.99%
ROICexgc 87.8%
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
FCFM 10.07%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Debt/EBITDA 0.55
Cap/Depr 149.83%
Cap/Sales 1.64%
Interest Coverage 13.04
Cash Conversion 105.36%
Profit Quality 123.49%
Current Ratio 1.58
Quick Ratio 0.92
Altman-Z 6.81
F-Score7
WACC9.9%
ROIC/WACC2.88
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
EPS Next Y19.15%
EPS Next 2Y11.39%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%
Revenue Next Year9.46%
Revenue Next 2Y6.93%
Revenue Next 3Y8.1%
Revenue Next 5Y4.99%
EBIT growth 1Y-0.36%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.1%
EBIT Next 3Y15.17%
EBIT Next 5Y13.76%
FCF growth 1Y34.94%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y45.83%
OCF growth 3YN/A
OCF growth 5Y14.81%